Skip to main content
. 2020 Dec 9;40(4):474–485. doi: 10.14366/usg.20148

Table 3.

Diagnostic performance of biopsy criteria by the modified K-TIRADS and five risk stratification systems in small nodules (≤2 cm) (n=2,385)

Ultrasound risk stratification systems Sensitivity (%) Specificity (%) PPV (%) NPV (%) LR+ LR- DOR AUC Reduction rate of unnecessary biopsies (%)a)
Modified K-TIRADS 86.6 (344/397) 67.6 (1,344/1,988) 34.8 (344/988) 96.2 (1,344/1,397) 2.67 0.20 13.55 0.771 67.6
[82.9-89.8] [65.5-69.7] [31.8-37.9] [95.1-97.1] [2.48-2.88] [0.15-0.25] [9.99-18.36] [0.754-0.788] [65.5-69.7]
AACE/ACE/AME 79.6 (316/397) 66.6 (1,325/1,988) 32.3 (316/979) 94.2 (1,325/1,406) 2.39 0.31 7.80 0.731 66.6
[75.3-83.5] [64.5-68.7] [29.4-35.3] [92.9-95.4] [2.20-2.58] [0.25-0.37] [6.00-10.12] [0.713-0.749] [64.6-68.7]
ACR TI-RADS 76.1 (302/397) 76.3 (1,517/1,988) 39.1 (302/773) 94.1 (1,517/1,612) 3.21 0.31 10.24 0.762 76.3
[71.6-80.2] [74.4-78.2] [35.6-42.6] [92.8-95.2] [2.92-3.54] [0.26-0.37] [7.95-13.18] [0.744-0.779] [74.4-78.2]
ATA 85.4 (339/397) 55.2 (1,098/1,988) 27.6 (339/1,229) 95.0 (1,098/1,156) 1.91 0.26 7.21 0.703 55.2
[81.5-88.7] [53.0-57.4] [25.1-30.2] [93.6-96.2] [1.79-2.03] [0.21-0.34] [5.38-9.66] [0.684-0.721] [53.0-57.4]
EU-TIRADS 84.1 (334/397) 54.2 (1,077/1,988) 26.8 (334/1,245) 94.5 (1,077/1,140) 1.84 0.29 6.27 0.692 54.2
[80.2-87.6] [52.0-56.4] [24.4-29.4] [93.0-95.7] [1.72-1.96] [0.23-0.37] [4.72-8.32] [0.673-0.710] [52.0-56.4]
K-TIRADS 96.2 (382/397) 27.4 (544/1,988) 20.9 (382/1,826) 97.3 (544/559) 1.32 0.14 9.59 0.618 27.4
[93.8-97.9] [25.4-29.4] [19.1-22.9] [95.6-98.5] [1.28-1.37] [0.08-0.23] [5.67-16.22] [0.598-0.637] [25.4-29.4]

Values in parentheses are number of nodules; values in square brackets are 95% confidence intervals.

K-TIRADS, Korean Thyroid Imaging Reporting and Data System; PPV, positive predictive value; NPV, negative predictive value; LR+, likelihood ratio for positive results; LR-, likelihood ratio for negative results; DOR, diagnostic odds ratio; AUC, area under the receiver operating characteristic curve; AACE/ACE/AME, American Association of Clinical Endocrinologists/American College of Endocrinology/Associazione Medici Endocrinologi Medical Guidelines; ACR TI-RADS, American College of Radiology Thyroid Imaging Reporting and Data System; ATA, American Thyroid Association Management Guideline; EU-TIRADS, European Thyroid Imaging Reporting and Data System.

a)

The reduction rate of unnecessary biopsies indicates the proportion of nodules not indicated for biopsy among all benign nodules.